Irritable Bowel Syndrome (IBS) is a chronic functional disorder of the digestive system that primarily affects the colon. It’s characterized by recurring abdominal discomfort and changes in bowel habits, such as diarrhea, constipation, or alternating between the two. IBS is a disorder of gut-brain interaction, meaning it’s not caused by structural damage or inflammation, but rather by dysfunction in intestinal motility and communication between the gut and brain.
IBS is extremely common, affecting 10-15% of the global population, with higher prevalence in women. While it doesn’t threaten life and doesn’t progress to serious conditions like colorectal cancer, it can significantly impact quality of life and daily functioning.
IBS symptoms vary from person to person, but the most common include:
- Abdominal pain or cramping — typically improves after bowel movements and worsens after meals
- Changes in bowel habits — diarrhea, constipation, or alternating between the two
- Bloating and swelling sensation — often with increased gas production
- Feeling of incomplete bowel emptying after going to the toilet
- Presence of mucus in stool
Many patients also report chronic fatigue, nausea, lower back pain, and symptoms affecting the urinary system. Symptoms typically appear in episodes, with periods of flare-ups and remission, and can be triggered by specific factors such as stress, certain foods, or hormonal changes.
Causes and Risk Factors
The exact causes of IBS aren’t fully understood, but research has identified various contributing factors:
- Gut-brain axis disruption — The two-way communication between the central nervous system and the gut is impaired, leading to heightened sensitivity and changes in intestinal motility
- Psychological factors — Stress, anxiety, and depression can trigger or worsen symptoms
- Digestive infections — Some patients develop IBS following acute gastroenteritis (post-infectious IBS)
- Intestinal microbiota imbalance — Changes in the composition of gut bacteria can affect intestinal function and immune response
- Low-grade inflammation and immune activation — Mast cell activation and release of inflammatory mediators can contribute to symptoms
- Genetic factors — Family history can increase the risk of developing the condition
Diagnosing IBS
IBS diagnosis is based primarily on clinical symptoms and the Rome IV Criteria. According to these criteria, IBS is diagnosed when there is:
- Recurring abdominal pain at least once weekly over the past three months, combined with at least two of the following:
- Relationship of pain to bowel movements
- Change in frequency of bowel movements
- Change in appearance or consistency of stool
- Symptoms must have started at least six months before diagnosis
Your doctor takes a detailed history, performs a clinical examination, and may request certain tests to rule out other conditions, such as:
- Blood tests — to exclude anemia, celiac disease, and inflammation
- Stool tests and fecal calprotectin — to rule out inflammatory bowel disease
- Endoscopy (gastroscopy, colonoscopy) — in selected cases, especially when alarm symptoms are present
It’s important to exclude alarm symptoms such as weight loss, bloody stools, nighttime symptoms, fever, or family history of colorectal cancer, as these might indicate other conditions.
Treatment and Management
IBS treatment is individualized and includes a combination of dietary, pharmacological, and psychological interventions.
Dietary Interventions
- Low FODMAP diet — One of the most effective dietary approaches, with symptom improvement in 70-76% of patients. This diet restricts short-chain carbohydrates that are easily fermented and can cause bloating, pain, and bowel changes
- Avoiding trigger foods — Fatty foods, caffeine, alcohol, spices, and dairy products may worsen symptoms in some patients
- Increasing dietary fiber — For patients with constipation, though this should be done gradually to avoid worsening bloating
Medication
Pharmacological treatment is selected based on subtype and symptom severity:
For IBS with constipation (IBS-C):
- Lubiprostone, linaclotide, plecanatide, tenapanor — Medications that increase fluid secretion in the intestines and accelerate intestinal motility
- Laxatives such as PEG (polyethylene glycol)
For IBS with diarrhea (IBS-D):
- Rifaximin — An antibiotic acting in the intestines that improves symptoms
- Loperamide — For symptomatic relief of diarrhea
- Alosetron — A serotonin antagonist (only in selected cases)
For all subtypes:
- Tricyclic antidepressants (TCAs) — Improve abdominal pain and intestinal function
- Antispasmodics — Reduce cramping and pain
- Probiotics — Certain strains may improve the composition of intestinal microbiota and symptoms
Psychological Therapies
- Cognitive-Behavioral Therapy (CBT) — Proven effective for managing stress and symptoms
- Gut-directed hypnotherapy — Has shown significant benefits, even with just a few sessions
Lifestyle Changes
- Regular physical exercise
- Stress management through relaxation techniques
- Adequate sleep and regular meal times
Prognosis and Quality of Life
IBS is a chronic condition that doesn’t threaten life, but it can significantly affect quality of life. Approximately 97% of patients report reduced quality of life, with impacts on social life (90%), sexual life (69%), and work performance (94%). Proper management can significantly improve symptoms and daily functioning.
When to See a Doctor
You should consult a doctor if:
- You experience persistent symptoms for more than four weeks
- You notice symptoms such as:
- Intestinal bleeding or blood in stool
- Unexplained weight loss
- Nighttime symptoms that wake you
- Fever
- Severe and worsening abdominal pain
- Family history of inflammatory bowel disease or colorectal cancer
Early diagnosis and appropriate treatment can significantly improve quality of life and effectively control IBS symptoms.